Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA258728
Max Phase: Preclinical
Molecular Formula: C9H14N3O8P
Molecular Weight: 323.20
Molecule Type: Small molecule
Associated Items:
ID: ALA258728
Max Phase: Preclinical
Molecular Formula: C9H14N3O8P
Molecular Weight: 323.20
Molecule Type: Small molecule
Associated Items:
Synonyms (1): Cytidine 3'-Phosphate
Synonyms from Alternative Forms(1):
Canonical SMILES: Nc1ccn([C@@H]2O[C@H](CO)[C@@H](OP(=O)(O)O)[C@H]2O)c(=O)n1
Standard InChI: InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-6(14)7(4(3-13)19-8)20-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1
Standard InChI Key: UOOOPKANIPLQPU-XVFCMESISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 323.20 | Molecular Weight (Monoisotopic): 323.0519 | AlogP: -2.45 | #Rotatable Bonds: 4 |
Polar Surface Area: 177.36 | Molecular Species: ACID | HBA: 9 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 11 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 0.87 | CX Basic pKa: | CX LogP: -2.92 | CX LogD: -6.75 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.37 | Np Likeness Score: 1.60 |
1. Ghosh KS, Debnath J, Dutta P, Sahoo BK, Dasgupta S.. (2008) Exploring the potential of 3'-O-carboxy esters of thymidine as inhibitors of ribonuclease A and angiogenin., 16 (6): [PMID:18226913] [10.1016/j.bmc.2008.01.003] |
2. Samanta A, Leonidas DD, Dasgupta S, Pathak T, Zographos SE, Oikonomakos NG.. (2009) Morpholino, piperidino, and pyrrolidino derivatives of pyrimidine nucleosides as inhibitors of ribonuclease A: synthesis, biochemical, and crystallographic evaluation., 52 (4): [PMID:19173562] [10.1021/jm800724t] |
3. Debnath J, Dasgupta S, Pathak T.. (2009) Nucleoside-amino acid conjugates: An alternative route to the design of ribonuclease A inhibitors., 17 (14): [PMID:19540766] [10.1016/j.bmc.2009.06.002] |
4. Dossi K, Tsirkone VG, Hayes JM, Matousek J, Poucková P, Soucek J, Zadinova M, Zographos SE, Leonidas DD.. (2009) Mapping the ribonucleolytic active site of bovine seminal ribonuclease. The binding of pyrimidinyl phosphonucleotide inhibitors., 44 (11): [PMID:19643512] [10.1016/j.ejmech.2009.06.039] |
5. Dutta S, Basak A, Dasgupta S.. (2010) Synthesis and ribonuclease A inhibition activity of resorcinol and phloroglucinol derivatives of catechin and epicatechin: Importance of hydroxyl groups., 18 (17): [PMID:20692173] [10.1016/j.bmc.2010.06.077] |
6. PubChem BioAssay data set, |
Source(2):